Puerto, Estela D.
HRN: 22-89-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2024
06/07/2024
IV
600 Mg
Q6
Infected Wound, 5th Digit Of Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes